Histopathology and prognosis of germ cell tumors metastatic to brain : cohort study
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
INTRODUCTION: Germ cell tumors (GCTs) are uncommon neoplasms predominantly arising in midline tissues. The prognostic significance of histopathology in predicting metastatic GCT behavior is poorly understood.
METHODS: Multicenter international cohort study including 29 patients with GCTs metastatic to brain were retrospectively investigated (18 patients from Mayo Clinic and 11 patients from the intracranial germ cell tumor genome analysis consortium in Japan). Clinical characteristics were analyzed using the Chi-square test (two-tailed) for categorical variables and using the log-rank test for survival data.
RESULTS: Median age at treatment was 31 years (range 14-58). Primary disease sites were testis (71%), mediastinum (18%), and female reproductive organs (11%). Median metastatic interval was 223 days (range, 6-6124). Median follow-up was 346 days (range, 1-5356), with 16 deaths (57%) occurring after the median overall survival of 455 days. Actuarial one-year survival was 51%; 12-of-16 deaths (75%) were attributed to intracranial disease. Appearance of the same GCT subtype at the metastatic site as the primary was high for non-seminomatous GCT (NSGCT, 64-100%), but low for seminoma/dysgerminoma and mature teratoma (MT, 14, 17%, respectively). Gain of a new component was seen in 4 (20%)-3 of which included embryonal carcinoma (EC) at the primary site (75%). Incidence of cases without seminoma/dysgerminoma increased significantly after metastasis (p = 0.02). Metastatic interval was shorter in cases with histological change (199 vs 454 days, p = 0.009). Overall survival was associated with MT primary histopathology (p = 0.02).
CONCLUSION: Histological differentiation at the primary GCT site influences metastatic prognosis. Aggressive behavior is associated with NSGCT, while EC frequently demonstrates multi-directional histological differentiation after brain metastasis, and such histological dynamism is associated with shorter metastatic interval. Most metastases occurred within one year of diagnosis, emphasizing the need for close surveillance in newly diagnosed extra-cranial GCT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:154 |
---|---|
Enthalten in: |
Journal of neuro-oncology - 154(2021), 1 vom: 17. Aug., Seite 121-130 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Takami, Hirokazu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Germ cell tumor |
---|
Anmerkungen: |
Date Completed 04.03.2022 Date Revised 04.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11060-021-03810-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM32818005X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32818005X | ||
003 | DE-627 | ||
005 | 20231225202413.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11060-021-03810-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1093.xml |
035 | |a (DE-627)NLM32818005X | ||
035 | |a (NLM)34272633 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Takami, Hirokazu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Histopathology and prognosis of germ cell tumors metastatic to brain |b cohort study |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.03.2022 | ||
500 | |a Date Revised 04.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a INTRODUCTION: Germ cell tumors (GCTs) are uncommon neoplasms predominantly arising in midline tissues. The prognostic significance of histopathology in predicting metastatic GCT behavior is poorly understood | ||
520 | |a METHODS: Multicenter international cohort study including 29 patients with GCTs metastatic to brain were retrospectively investigated (18 patients from Mayo Clinic and 11 patients from the intracranial germ cell tumor genome analysis consortium in Japan). Clinical characteristics were analyzed using the Chi-square test (two-tailed) for categorical variables and using the log-rank test for survival data | ||
520 | |a RESULTS: Median age at treatment was 31 years (range 14-58). Primary disease sites were testis (71%), mediastinum (18%), and female reproductive organs (11%). Median metastatic interval was 223 days (range, 6-6124). Median follow-up was 346 days (range, 1-5356), with 16 deaths (57%) occurring after the median overall survival of 455 days. Actuarial one-year survival was 51%; 12-of-16 deaths (75%) were attributed to intracranial disease. Appearance of the same GCT subtype at the metastatic site as the primary was high for non-seminomatous GCT (NSGCT, 64-100%), but low for seminoma/dysgerminoma and mature teratoma (MT, 14, 17%, respectively). Gain of a new component was seen in 4 (20%)-3 of which included embryonal carcinoma (EC) at the primary site (75%). Incidence of cases without seminoma/dysgerminoma increased significantly after metastasis (p = 0.02). Metastatic interval was shorter in cases with histological change (199 vs 454 days, p = 0.009). Overall survival was associated with MT primary histopathology (p = 0.02) | ||
520 | |a CONCLUSION: Histological differentiation at the primary GCT site influences metastatic prognosis. Aggressive behavior is associated with NSGCT, while EC frequently demonstrates multi-directional histological differentiation after brain metastasis, and such histological dynamism is associated with shorter metastatic interval. Most metastases occurred within one year of diagnosis, emphasizing the need for close surveillance in newly diagnosed extra-cranial GCT | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Germ cell tumor | |
650 | 4 | |a Metastasis | |
650 | 4 | |a Prognosis | |
700 | 1 | |a Graffeo, Christopher S |e verfasserin |4 aut | |
700 | 1 | |a Perry, Avital |e verfasserin |4 aut | |
700 | 1 | |a Ohno, Makoto |e verfasserin |4 aut | |
700 | 1 | |a Ishida, Joji |e verfasserin |4 aut | |
700 | 1 | |a Giannini, Caterina |e verfasserin |4 aut | |
700 | 1 | |a Narita, Yoshitaka |e verfasserin |4 aut | |
700 | 1 | |a Nakazato, Yoichi |e verfasserin |4 aut | |
700 | 1 | |a Saito, Nobuhito |e verfasserin |4 aut | |
700 | 1 | |a Nishikawa, Ryo |e verfasserin |4 aut | |
700 | 1 | |a Matsutani, Masao |e verfasserin |4 aut | |
700 | 1 | |a Ichimura, Koichi |e verfasserin |4 aut | |
700 | 1 | |a Daniels, David J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neuro-oncology |d 1993 |g 154(2021), 1 vom: 17. Aug., Seite 121-130 |w (DE-627)NLM012591793 |x 1573-7373 |7 nnns |
773 | 1 | 8 | |g volume:154 |g year:2021 |g number:1 |g day:17 |g month:08 |g pages:121-130 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11060-021-03810-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 154 |j 2021 |e 1 |b 17 |c 08 |h 121-130 |